Technical / White Paper
Supply Chain Solutions for the Growing Orphan Drug Market
Marken recognizes the pharma industry’s increased focus on rare disease treatments and the complexity of safely transporting them to patients residing in multiple countries, each with its own unique customs and regulatory requirements. Marken’s Direct to Patient service utilizes its team of experts in customs and trade compliance along with its extensive network of depot facilities and strategically located distribution centers throughout the world to provide timely global packaging, transport and tracking of orphan drug materials within regulatory, temperature and time constraints.
